Poolbeg Pharma (POLB) RNS Announcements

Add to Alert list
Date Time Source Announcement
01 Jul 2025 04:24 PM
RNS
Notification of Major Holdings
26 Jun 2025 07:00 AM
RNS
Notification of Major Holdings
25 Jun 2025 08:00 AM
RNS
Director/PDMR Shareholding
23 Jun 2025 02:57 PM
RNS
Results of GM and AGM Meetings
27 May 2025 07:01 AM
RNS
FDA Orphan Drug Designation granted for POLB 001
27 May 2025 07:01 AM
RNS
FDA Orphan Drug Designation granted for POLB 001
27 May 2025 07:00 AM
RNS
Annual Report, AGM Notice & Circular
23 May 2025 07:00 AM
RNS
Result of upsized oversubscribed BookBuild Offer
22 May 2025 01:44 PM
RNS
Increase of BookBuild Offer
20 May 2025 12:26 PM
RNS
Result of Placing and Notice of General Meeting
20 May 2025 07:02 AM
RNS
Proposed Retail Offer to raise up to £100,000
20 May 2025 07:01 AM
RNS
Proposed Fundraising to raise approximately £4.1M
20 May 2025 07:00 AM
RNS
Results for the year ended 31 December 2024
27 Mar 2025 07:00 AM
RNS
Conference Participation in March & April 2025
20 Mar 2025 07:00 AM
RNS
POLB 001 Patent Granted in Korea
25 Feb 2025 08:50 AM
RNS
Form 8.5 (EPT/NON-RI)
24 Feb 2025 08:48 AM
RNS
Form 8.5 (EPT/NON-RI)
21 Feb 2025 11:53 AM
GNW
Form 8.5 (EPT/RI) - Poolbeg Pharma Plc
21 Feb 2025 07:00 AM
RNS
Termination of proposed combination with HOOKIPA
20 Feb 2025 08:06 PM
GNW
HOOKIPA Pharma Inc. (“HOOKIPA”) Statement reg...
20 Feb 2025 09:03 AM
RNS
Form 8.5 Poolbeg Pharma Plc
20 Feb 2025 08:53 AM
RNS
Form 8.5 (EPT/NON-RI)
20 Feb 2025 07:49 AM
GNW
Form 8.5 (EPT/RI) - Poolbeg Pharma Plc
19 Feb 2025 12:35 PM
GNW
Form 8.5 (EPT/RI) - Poolbeg Pharma Plc
18 Feb 2025 05:35 PM
RNS
Holding(s) in Company
18 Feb 2025 05:04 PM
RNS
Form 8.3 - Poolbeg Pharma plc
18 Feb 2025 10:17 AM
GNW
Form 8.5 (EPT/RI) - Poolbeg Pharma Plc
17 Feb 2025 10:28 AM
GNW
Form 8.5 (EPT/RI) - Poolbeg Pharma Plc
14 Feb 2025 10:25 AM
GNW
Form 8.5 (EPT/RI) - Poolbeg Pharma Plc
14 Feb 2025 09:11 AM
RNS
Form 8.5 Poolbeg Pharma Plc
13 Feb 2025 11:17 AM
GNW
Form 8.5 (EPT/RI) - Poolbeg Pharma Plc
13 Feb 2025 10:30 AM
RNS
Form 8.5 Poolbeg Pharma Plc
12 Feb 2025 10:52 AM
GNW
Form 8.5 (EPT/RI) - Poolbeg Pharma Plc
12 Feb 2025 09:08 AM
RNS
Form 8.5 Poolbeg Pharma Plc
11 Feb 2025 09:46 AM
GNW
Form 8.5 (EPT/RI) - Poolbeg Pharma Plc
11 Feb 2025 08:42 AM
RNS
Form 8.5 Poolbeg Pharma Plc
10 Feb 2025 10:59 AM
GNW
Form 8.5 (EPT/RI) - Poolbeg Pharma Plc
10 Feb 2025 08:56 AM
RNS
Form 8.5 Poolbeg Pharma Plc
07 Feb 2025 11:40 AM
GNW
Form 8.5 (EPT/RI) - Poolbeg Pharma Plc
06 Feb 2025 10:36 AM
GNW
Form 8.5 (EPT/RI) - Poolbeg Pharma Plc
05 Feb 2025 10:26 AM
GNW
Form 8.5 (EPT/RI) - Poolbeg Pharma Plc
05 Feb 2025 09:20 AM
RNS
Form 8.5 Poolbeg Pharma Plc
04 Feb 2025 11:40 AM
GNW
Form 8.5 (EPT/RI) - Poolbeg Pharma Plc
03 Feb 2025 11:28 AM
GNW
Form 8.5 (EPT/RI) - Poolbeg Pharma Plc
03 Feb 2025 10:59 AM
RNS
Form 8.5 Poolbeg Pharma Plc
31 Jan 2025 11:46 AM
GNW
Form 8.5 (EPT/RI) - Poolbeg Pharma Plc
31 Jan 2025 09:13 AM
RNS
Form 8.5 - Poolbeg Pharma Plc
30 Jan 2025 10:34 AM
GNW
Form 8.5 (EPT/RI) - Poolbeg Pharma Plc
30 Jan 2025 09:04 AM
RNS
Form 8.5 Poolbeg Pharma Plc
30 Jan 2025 07:00 AM
RNS
Offer Update - Extension to PUSU Deadline

Poolbeg Pharma is a biopharmaceutical company that develops and commercialises medicines for unmet medical needs, including rare and orphan diseases. Poolbeg Pharma focuses on developing medicines for areas of high unmet need, such as cancer immunotherapy-induced CRS, infectious disease, and metabolic conditions like obesity. It is listed on the stock exchange under the ticker POLB.

POLB share price launched at 11p in 2021.

 

UK 100

Latest directors dealings